tiprankstipranks
Trending News
More News >

Cognition Therapeutics price target lowered to $3 from $5 at H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Cognition Therapeutics (CGTX) to $3 from $5 and keeps a Buy rating on the shares. The firm cites the anticipated equity dilution later this year to extend the company’s operational runway for the target cut. Zervimesine appears applicable across multiple fronts, the analyst tells investors in a research note.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1